close and back to page

Latest News

Latest News

Abbott: Study Shows Nutrition Program Could Save Hospitals Up to $3,800 Per Patient

One in three people enter a hospital malnourished or at risk of malnutrition.

Making sure people stay nourished in the hospital has shown to help patients recover, and real-world evidence confirms its cost benefits too. The research, published in American Health & Drug Benefits journal and supported by Abbott (No. 10 on the DiversityInc Top 50 Companies list), found that when Advocate Health Care implemented a nutrition care program at four of its Chicago area hospitals, it showed more than $4.8 million in cost savings due to shorter hospital stays and lower readmission rates.3


Addressing malnutrition is a growing concern, as 1 in 3 people enter the hospital malnourished or at risk of malnutrition.1-2  Decades of research prove that when patients are poorly nourished, it can impact their recovery, including higher risk of complications (such as pressure ulcers, infections and falls) and more frequent readmissions. Studies also show that poor nutrition can cause increased costs of care and longer hospital stays–with the average hospital stay costing nearly $2,000 per day.4 As a result, hospitals and health care systems, such as Advocate Health Care, are looking at the value of nutrition to improve care and help patients get back to living a healthier life.

Starting in 2014, Advocate Health Care implemented two models of a nutrition care program for patients at-risk of malnutrition, and the results from this study published in December 2016, found that doing so reduced 30-day readmission rates by 27 percent and the average hospital stay by nearly two days.5 To evaluate the cost-savings of this program, researchers used a novel, web-based budget impact model to assess the potential cost savings from the avoided readmissions and reduced time in hospital. Compared to the hospitals' previous readmission rates and patients' average length of stay, researchers found that optimizing nutrition care in the four hospitals resulted in roughly $3,800 cost savings per patient treated for malnutrition.

"Value-based care means looking comprehensively at patient care to identify gaps and opportunities for improvement," said Lee Sacks, MD, executive vice president and chief medical officer of Advocate Health Care. "The study's findings demonstrate that modest changes in the way we care for patients, such as ensuring patients are nourished during their hospital stay, can have a big impact in reducing costs and improving health outcomes."

"This research confirms that implementing nutrition-focused quality improvement programs, like the ones at Advocate Health Care, can help patients recover from their hospitalization faster while also removing some of the burden of financial pressures placed on health systems today," said Suela Sulo, PhD, a health outcomes researcher at Abbott and lead author of the cost impact study. "As providers, administrators, and payers face added pressures from rising healthcare costs, value-based nutrition interventions should be considered in all hospitals across the U.S."

About the QIP Study:

A Comprehensive Nutrition-focused Quality Improvement Program Reduces 30-day Readmissions and Length of Stay in Hospitalized Patients, published in Journal of Parenteral and Enteral Nutrition in December 2016, was a multi-site, two-group, pre-post study to evaluate two nutrition Quality Improvement Programs (QIP) at four Advocate Health Care hospitals.

The study's primary outcome was 30-day unplanned readmissions, with a secondary outcome of hospital length of stay. A total of 1,269 participants aged 18+ at risk of malnutrition were enrolled between October 13, 2014 and April 2, 2015.

The study was funded by Abbott, which had no role in data collection or analysis.

References

1. Coats KG et al. J Am Diet Assoc. 1993; 93:27–33.

2. Thomas DR et al. Am J Clin Nutr. 2002; 75: 308-313.

3. Sulo S et al. Am Health Drug Benefits, 2017 ; 10 (5): 262-270.

4. HCUP Fast Stats. Healthcare Cost and Utilization Project (HCUP). December 2016. Agency for Healthcare Research and Quality, Rockville, MD. www.hcup-us.ahrq.gov/faststats/national/inpatienttrends.jsp.

5. Sriram K et al. JPEN. 2016; 40(1):1

Abbott: Top Internship for Healthcare and Tech

Interns have spoken: Abbott is the top college internship program for healthcare and tech & engineering.

Originally Published by Abbott.

Abbott recognizes the need to develop its future leaders early, and has been named the top healthcare and tech & engineering internship program by Vault.

Read More Show Less

New Study Shows Abbott's Novel Diagnostic Test Could Help Rule Out Heart Attacks Earlier

Preliminary research indicates that a diagnostic test currently in development, that is done at the patient's side in minutes, has similar accuracy to a high-sensitive troponin test for early rule out of a heart attack .

Originally Published by Abbott.

For someone experiencing cardiac symptoms in the emergency room, every minute matters as physicians determine whether someone is having a heart attack. New data, published online in JAMA Cardiology, found a new blood test under development that is done right at the patient's side in as little as 15 minutes could identify nearly three-fifths (56.7 percent) of people at low-risk of experiencing a heart attack, similar to the results of a High Sensitive Troponin-I blood test done in the laboratory setting.

Read More Show Less

Abbott: Partnering for a Healthier Future

Abbott supports the First Ladies of Africa in the fight to end AIDS in children and keep mothers healthy.

Originally Published by Abbott.

In countries around the world, Abbott is working across its businesses and in partnerships with others to create healthier futures for families. One example: since 2014, Abbott's diagnostics business has supported the work of the Organization of African First Ladies Against HIV/AIDS (OAFLA – pictured above) to fight the AIDS epidemic in Africa, particularly among pregnant women and children – who are among the most vulnerable populations impacted by the disease.

At an OAFLA meeting on the sidelines of the UN General Assembly in New York City, Abbott and several other organizations are being recognized by OAFLA for longstanding partnership and support, including public-private partnerships that bring together technical, financial and other resources to focus on a global health challenge such as HIV/AIDS.

Read More Show Less

Abbott: DRG Stimulator, A Life Changing Technology for Chronic Pain.

The new technological DRG therapy may be the key to easing daily tasks for those with chronic pain.

Originally Published by Abbott.

Living with chronic pain affects not just your body but also your mind. It can make getting around and getting along equally difficult.

But with innovation in health technology comes hope. Abbott has developed a new device found to be more effective than traditional therapy at relieving chronic pain.

Read More Show Less

Abbott: Expediting Blood Testing With i-Stat

The portable, handheld i-STAT Alinity delivers quick blood test results anywhere you are.

Originally Published by Abbott.

Every day, countless blood samples are tested all around the world for one purpose: to help diagnose and treat medical conditions. From the couple eagerly awaiting the results of a pregnancy blood test to a worried cancer patient hoping for more answers, diagnostic blood tests give vital insight into what's happening underneath the skin.

Read More Show Less

Abbott: Freestyle Libre 14 Day, Now FDA Approved

Abbott's flash glucose monitor now FDA-approved for two weeks of use in U.S. between sensor changes.

Originally Published by Abbott.

The U.S. Food and Drug Administration has approved FreeStyle Libre 14 day— Abbott's revolutionary continuous glucose monitoring system. In the U.S., you can wear the sensor up to 14 days with high accuracy.

Read More Show Less

At Abbott, You Look Like An Engineer

Decades before #ILookLikeAnEngineer, Abbott paved the way for a non-profit dedicated to diversity in STEM.

Originally Published by Abbott.

#ILookLikeAnEngineer.

Remember this? A few years ago, a young software engineer was featured in a recruiting advertisement, only to be accused of not being an actual engineer. Frustrated with the assertion, Isis Wenger started a movement to break the stereotype of what an engineer should look like.

Read More Show Less

Abbott Receives FDA Approval for Next-Generation MitraClip Device to Treat People with Leaky Heart Valves

MitraClip is the gold-standard minimally invasive alternative to open-heart surgery for people needing mitral valve repair.

Originally Published by Abbott.

Abbott announced it received approval from the U.S. Food and Drug Administration (FDA) for a next-generation version of its leading MitraClip® heart valve repair device used to repair a leaky mitral valve without open-heart surgery. The transcatheter clip-based therapy, now on a third generation of product innovations, has been used to treat more than 65,000 patients worldwide over the last ten years.

Read More Show Less